Dr. Paul Sax discusses the newly approved flu drug in
HIV and ID Observations.
In the latest HIV and ID Observations blog post, Dr. Paul Sax takes a look at the new flu drug that the FDA approved last week. It offers convenience, fast activity, and a novel mechanism, but at a price!
Want to see more from NEJM Journal Watch? Register here.